I
IxLayer
Digital health company focused on improving the delivery of lab testing
About IxLayer
Ixlayer is a healthcare technology startup that provides diagnostic laboratory testing solutions for a variety of clients including health plans, retailers, and biopharma companies. The company operates in the healthcare market, specifically in the diagnostic testing sector, and aims to make diagnostic testing more accessible and affordable.
Read full description
Ixlayer's business model revolves around offering fully integrated, custom solutions that enable clients to offer a personalized healthcare experience. They have powered over 1,100 nationwide programs and millions of diagnostic tests annually. Their services include providing custom test kits, lab services, reporting, and health maintenance.
The company generates revenue by offering these services to their clients. Health plans use ixlayer's white-labeled kits and cloud-based platform to close gaps in care. Retailers, such as pharmacies, use ixlayer's solutions to bring diagnostic testing products, preventive health, and wellness programs to market faster and manage them more efficiently. Biopharma companies leverage ixlayer's ecosystem to maximize therapeutic and commercial success.
Ixlayer's technology ensures a precise and secure flow of information, as well as an engaging and delightful patient or consumer experience. The company has also played a significant role in mitigating the spread of COVID-19 by providing a testing platform for the United States Coast Guard.
At a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- San Francisco, United States
- Employees
- 40
- Open positions
- None listed
- Dealroom signal
- 66.2/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Personal Health, Cloud Data Services, Cloud Infrastructure, Testing, Infrastructure Services, Biotechnology, Genetics and genomics, Precision Medicine, Tech for Hospitals and Clinics
- Technology
- Hardware
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | Aug 2021 | $0 | — | Salesforce Ventures · Accenture Ventures | — |
| SERIES AOther financing | Mar 2021 | $75M | $300M | Zeshan Muhammedi · Pear Ventures · Dara Khosrowshahi · General Catalyst | — |
Growth signals
Latest recorded traffic for IxLayer is 3.2K monthly website visits, up 88.2% over the last three months. IxLayer's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A10 investors entered at this stage
FundRx
General Catalyst
Zeshan Muhammedi
Pear Ventures
Dara Khosrowshahi
Bobby Yazdani
Anne Wojcicki
Hamid R. Moghadam
Salesforce Ventures
Accenture Ventures
Other known investors1 additional known investor
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about IxLayer on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See IxLayer’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.